by microsens | Apr 8, 2020 | RapiPREP
Following the clinical validation of the MicrosensDx RapiPrep® COVID-19 clinical diagnostic test, one of the lead researchers in the clinical study, Dr Claire Steves of Kings College London, was interviewed on Sky News. When asked about the benefits of the test, Dr...
by microsens | Apr 3, 2020 | RapiPREP
London, 20th March 2020 With the imminent threat of the coronavirus (SARS-CoV-2) forcing countries worldwide into lockdown and putting a severe strain on healthcare services, MicrosensDx has responded by adapting its current range of infectious disease rapid detection...
by microsens | Apr 3, 2020 | RapiPREP
London, 31st March 2020 On 20th March MicrosensDx announced that it had launched its fast and safe molecular test for research use in the detection of RNA from the SARS-Cov-2 virus in sputum, throat and nose swabs. MicrosensDx can now announce that the test has been...
by microsens | Apr 3, 2020 | RapiPREP
London, 3rd April 2020 MicrosensDx is delighted to announce that the clinical study which validated its RapiPrep® COVID-19 clinical diagnostic test has been accepted for publication. The study was conducted with leading research teams headed by Professor Tim Spector,...
